Niall Lennon

Ph.D.
Senior Director, Genomics Platform at the Broad Institute of MIT and Harvard
Share this profile
Niall J Lennon, Ph.D. is the Senior Director of the Genomics Platform at the Broad Institute of
MIT and Harvard, where he is also an Institute Scientist. He is also the Chief Scientific Officer
and Chair of the Board of Managers of Broad’s clinical testing laboratory, Broad Clinical Labs,
LLC. Dr. Lennon is also an Associate Director of the Gerstner Center for Cancer Diagnostics. He
oversees the development, implementation, and validation of disruptive technologies to serve

basic research, clinical research, and clinical diagnostics.

Dr. Lennon has been with the Broad since 2005 and has contributed to the development of
applications for every major massively parallel sequencing platform across a range of fields. In
2013, Dr. Lennon built a CLIA/CAP licensed clinical laboratory at the Broad to facilitate return
of results to patients and to support clinical trials. More recently, Dr. Lennon has led efforts to
achieve FDA approval for both large-scale genomics projects (as co-Chair of the regulatory
working group for NIH’s All of Us Research Project) and for Broad’s own clinical diagnostic for
COVID-19 testing process that delivered >37 million diagnostic test results to people in the New

England region.

Dr Lennon received a Ph.D. in Pharmacology from University College Dublin and completed his
Postdoctoral studies at Harvard Medical School and Massachusetts General Hospital. He holds an
executive certificate in management from the MIT Sloan School of Management. Lennon is also
an Adjunct Professor of Biomedical Engineering at Tufts University.